Thrive Capital Management, LLC Pfizer Inc Transaction History

Thrive Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	SELL	$26.13 - $33.94 $101,201 - $131,449	-3,873 Reduced 27.76%	10,081 $290,000
Q3 2023 Nov 02, 2023	BUY	$32.09 - $37.51 $5,776 - $6,751	180 Added 1.31%	13,954 $462,000
Q2 2023 Aug 02, 2023	BUY	$36.12 - $41.79 $41,971 - $48,559	1,162 Added 9.21%	13,774 $505,000
Q1 2023 May 08, 2023	BUY	$39.39 - $51.28 $92,015 - $119,790	2,336 Added 22.73%	12,612 $514,000
Q4 2022 Jan 18, 2023	BUY	$41.75 - $54.5 $60,078 - $78,425	1,439 Added 16.28%	10,276 $0
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $92,902 - $113,410	2,123 Added 31.62%	8,837 $387,000
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $62,862 - $74,534	1,351 Added 25.19%	6,714 $352,000
Q1 2022 May 06, 2022	BUY	$45.75 - $56.69 $67,984 - $84,241	1,486 Added 38.33%	5,363 $278,000
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $160,197 - $237,466	3,877 New	3,877 $229,000
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $216,581 - $278,217	-5,518 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $198,151 - $224,472	5,518 New	5,518 $216,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Thrive Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Thrive Capital Management, LLC with notifications on news.